scholarly journals Metastasis-associated Protein 1/Histone Deacetylase 4-Nucleosome Remodeling and Deacetylase Complex Regulates Phosphatase and Tensin Homolog Gene Expression and Function

2012 ◽  
Vol 287 (33) ◽  
pp. 27843-27850 ◽  
Author(s):  
Sirigiri Divijendra Natha Reddy ◽  
Suresh B. Pakala ◽  
Poonam R. Molli ◽  
Neil Sahni ◽  
Narasimha Kumar Karanam ◽  
...  
2020 ◽  
Author(s):  
Kosuke Kataoka ◽  
Andras Bilkei-Gorzo ◽  
Andreas Zimmer ◽  
Toru Asahi

ABSTRACTMitochondrial autophagy (mitophagy) is an essential and evolutionarily conserved process that maintains mitochondrial integrity via the removal of damaged or superfluous mitochondria in eukaryotic cells. Phosphatase and tensin homolog (PTEN)-induced putative kinase 1 (PINK1) and Parkin promote mitophagy and function in a common signaling pathway. PINK1-mediated ubiquitin phosphorylation at Serine 65 (Ser65-pUb) is a key event in the efficient execution of PINK1/Parkin-dependent mitophagy. However, few studies have used immunohistochemistry to analyze Ser65-pUb in the mouse. Here, we examined the immunohistochemical characteristics of Ser65-pUb in the mouse hippocampus. Some hippocampal cells were Ser65-pUb positive, whereas the remaining cells expressed no or low levels of Ser65-pUb. PINK1 deficiency resulted in a decrease in the density of Ser65-pUb-positive cells, consistent with a previous hypothesis based on in vitro research. Interestingly, Ser65-pUb-positive cells were detected in hippocampi lacking PINK1 expression. The CA3 pyramidal cell layer and the dentate gyrus (DG) granule cell layer exhibited significant reductions in the density of Ser65-pUb-positive cells in PINK1-deficient mice. Moreover, Ser65-pUb immunoreactivity colocalized predominantly with neuronal markers. These findings suggest that Ser65-pUb may serve as a biomarker of in situ PINK1 signaling in the mouse hippocampus; however, the results should be interpreted with caution, as PINK1 deficiency downregulated Ser65-pUb only partially.


Blood ◽  
2013 ◽  
Vol 122 (21) ◽  
pp. 2253-2253 ◽  
Author(s):  
Jeffrey R Shearstone ◽  
John H van Duzer ◽  
Simon S Jones ◽  
Matthew Jarpe

Abstract Induction of HbF is an established therapeutic strategy for the treatment of sickle cell disease (SCD), and could also be effective in treating beta-thalassemia (bT). Fetal beta-like globin gene (HbG) expression is silenced in adults partly through the nucleosome remodeling and histone deacetylase (NuRD) complex, which contains HDAC1/2 (Sankaran VG, Science, 2008). Genetic ablation of HDAC1 or HDAC2, but not HDAC3, results in the induction of HbG expression (Bradner JE, Proc Natl Acad Sci, 2010). Furthermore, we have previously shown that selective chemical inhibitors of HDAC1 and 2 elicit a dose and time dependent induction of HbG mRNA and HbF protein in cultured human CD34+ bone marrow cells undergoing erythroid differentiation (Shearstone JS, ASH Annual Meeting Abstracts, 2012). However, the mechanism through which HDAC1/2 inhibition leads to activation of HbG remains largely unknown. In this work, we have utilized our proof of concept molecule, ACY-957, to investigate changes in gene expression and chromatin organization that result from inhibition of HDAC1/2. Gene expression profiling was performed on cells treated with ACY-957 (n=3) or vehicle (n=3) using Affymetrix PrimeView GeneChips. Treatment of early erythroblasts (CD71+, GlyA-) resulted in the up and down regulation of 1294 and 681 transcript probe sets, respectively. In comparison, treatment of late erythroblasts (CD71+, GlyA+) resulted in a total of 255 transcript probe set changes. This finding is consistent with follow-up experiments demonstrating that ACY-957 is unable to induce HbG in cells positive for both CD71 and GlyA. Taken together, these results suggest that erythroblasts become less responsive to HDAC inhibition as they mature. Gene set enrichment analysis using public domain data revealed that genes up- or down-regulated by HDAC1/2 shRNA knockdown are significantly overrepresented in the list of genes induced or repressed by ACY-957, respectively; suggesting pharmacologic inhibition of HDAC1/2 recapitulates genetic ablation. We also identified significant enrichment in other gene sets involving targets linked to HbG regulation, including lysine-specific demethylase 1 (LSD1) (Shi L, Nature Medicine, 2012). GeneChip and quantitative real-time PCR time course experiments show ACY-957 treatment leads to a decrease in Bcl11A (2-fold) and Sox6 (10-fold) mRNA, known repressors of fetal globin synthesis, and an increase in Klf2 (2-fold) and Gata2 (8-fold) mRNA, proposed fetal globin activators. This result is consistent with work by others that show Gata2 is suppressed, in part, by the NuRD complex (Hong W, EMBO Journal, 2005) and that Gata2 binding at the HbG promoter leads to increased levels of HbG expression (Zhu X, PLoS One, 2012). Interestingly, Gata2 induction preceded Sox6 suppression in ACY-957 treated cells and the Sox6 promoter contains 8 canonical WGATAR binding sites and one Gata2-specific binding motif, raising the possibility suppression of Sox6 by ACY-957 is mediated by Gata2 induction. To investigate these possibilities, we have performed chromatin immunoprecipitation coupled with next generation sequencing (ChIP-seq) for HDAC1, HDAC2, Gata2, and the HDAC2-specific histone modification H3K56 in ACY-957 and vehicle treated cells. These experiments will be discussed. ChIP-seq data, both by itself and in combination with gene expression data, will provide further insight into the mechanism through which HDAC1/2 regulates HbF synthesis. Disclosures: Shearstone: Acetylon Pharmaceuticals, Inc.: Employment, Equity Ownership. van Duzer:Acetylon Pharmaceuticals, Inc.: Employment, Equity Ownership. Jones:Acetylon Pharmaceuticals, Inc: Employment, Equity Ownership. Jarpe:Acetylon Pharmaceuticals, Inc.: Employment, Equity Ownership.


2017 ◽  
Vol 114 (37) ◽  
pp. 9942-9947 ◽  
Author(s):  
Nicholas Lister ◽  
Galina Shevchenko ◽  
James L. Walshe ◽  
Jessica Groen ◽  
Per Johnsson ◽  
...  

RNA has been found to interact with chromatin and modulate gene transcription. In human cells, little is known about how long noncoding RNAs (lncRNAs) interact with target loci in the context of chromatin. We find here, using the phosphatase and tensin homolog (PTEN) pseudogene as a model system, that antisense lncRNAs interact first with a 5′ UTR-containing promoter-spanning transcript, which is then followed by the recruitment of DNA methyltransferase 3a (DNMT3a), ultimately resulting in the transcriptional and epigenetic control of gene expression. Moreover, we find that the lncRNA and promoter-spanning transcript interaction are based on a combination of structural and sequence components of the antisense lncRNA. These observations suggest, on the basis of this one example, that evolutionary pressures may be placed on RNA structure more so than sequence conservation. Collectively, the observations presented here suggest a much more complex and vibrant RNA regulatory world may be operative in the regulation of gene expression.


2013 ◽  
Author(s):  
Κωνσταντίνος Νάκος

Η πρωτεΐνη HURP (Hepatoma Up-Regulated protein) έχει αναγνωριστεί ως παράγονταςσυναρμολόγησης της ατράκτου (SAF) που ρυθμίζεται από τη RanGTP. Αρχικά βρέθηκε σε μιτωτικάεκχυλίσματα αυγών Xenopus laevis, σε σύμπλοκο με τις TPX2, XMAP215, Eg5 και Aurora A. Η HURPπροσδένεται στους μικροσωληνίσκους, εντοπίζεται κυρίως στους μικροσωληνίσκους των κινητοχώρωνκαι είναι απαραίτητη για την σωστή συναρμολόγηση της μιτωτικής ατράκτου. Παρόλο αυτά, πρωτεΐνεςπου αλληλεπιδρούν με τη HURP σε ανθρώπινα κύτταρα παραμένουν άγνωστες.Σε αυτή τη μελέτη περιγράφουμε την αναγνώριση μίας νέας πρωτεΐνης που αλληλεπιδρά με τη HURP,τη CHD4 (Chromodomain Helicase DNA binding protein 4) μία ATPάση της αναδιαμόρφωσης τηςχρωματίνης και καταλυτική υπομονάδα του συμπλόκου αποκετυλασών που ευθύνεται για τηναναδιαμόρφωση του νουκλεοσώματος (Nucleosome remodeling and histone Deacetylase - NuRD).Πρόσφατα η πρωτεΐνη CHD4 αναγνωρίστηκε ως πρωτεΐνη που προσδένεται στους μικροσωληνίσκουςκαι ρυθμίζεται από την RanGTP.Οι μελέτες μας σε ανθρώπινα κύτταρα έδειξαν ότι η CHD4 κατά τη μίτωση απελευθερώνεται από ταμιτωτικά χρωμοσώματα και εντοπίζεται στην άτρακτο, υποδεικνύοντας ένα καινούριο ρόλο της CHD4στη συναρμολόγηση της ατράκτου. Για να κατανοήσουμε τη λειτουργία της CHD4 πραγματοποιήσαμεμελέτες απαλοιφής της CHD4 με την τεχνική της αποσιώπισης γονιδίου με siRNA. Μείωση της CHD4προκαλεί βλάβες στη συναρμολόγηση της μιτωτικής ατράκτου και στη στοίχιση των χρωμοσωμάτωνστις αρχές της μίτωσης, οδηγώντας σε ανώμαλο διαχωρισμό των χρωμοσωμάτων. Επιπλέον, ηαπώλεια της CHD4 επηρρεάζει τη σταθερότητα των K-fibers μειώνοντας σημαντικά την ποσότητα των μικροσωληνίσκων των κινητοχώρων. Μετά την απαλοιφή της CHD4, ο εντοπισμός της HURP βρέθηκενα αλλάζει, χάνοντας την προτίμησή της για τους μικροσωληνίσκους, των κινητοχώρων,υποδεικνύοντας την πιθανή ρύθμιση του εντοπισμού της HURP από την CHD4. Τέλος από in vitro καιin vivo πειράματα, βρήκαμε ότι η CHD4 αλληλεπιδρά με τη μιτωτική κινάση Aurora A και την πρωτεΐνηTPX2 που συνδέεται με μικροσωληνίσκους, δημιουργώντας ένα καινούριο σύμπλοκο σημαντικό για τηλειτουργία της μιτωτικής ατράκτου στα κύτταρα θηλαστικών.


2020 ◽  
Vol 21 (15) ◽  
pp. 5337 ◽  
Author(s):  
Fabiana Conciatori ◽  
Chiara Bazzichetto ◽  
Italia Falcone ◽  
Ludovica Ciuffreda ◽  
Gianluigi Ferretti ◽  
...  

Mounting preclinical and clinical evidence indicates that rewiring the host immune system in favor of an antitumor microenvironment achieves remarkable clinical efficacy in the treatment of many hematological and solid cancer patients. Nevertheless, despite the promising development of many new and interesting therapeutic strategies, many of these still fail from a clinical point of view, probably due to the lack of prognostic and predictive biomarkers. In that respect, several data shed new light on the role of the tumor suppressor phosphatase and tensin homolog on chromosome 10 (PTEN) in affecting the composition and function of the tumor microenvironment (TME) as well as resistance/sensitivity to immunotherapy. In this review, we summarize current knowledge on PTEN functions in different TME compartments (immune and stromal cells) and how they can modulate sensitivity/resistance to different immunological manipulations and ultimately influence clinical response to cancer immunotherapy.


Author(s):  
Cristina Sánchez-Puelles ◽  
María Calleja-Felipe ◽  
Alberto Ouro ◽  
Ghassen Bougamra ◽  
Ana Arroyo ◽  
...  

Abstract Phosphatase and tensin homolog on chromosome 10 (PTEN) is a tumor suppressor and autism-associated gene that exerts an important influence over neuronal structure and function during development. In addition, it participates in synaptic plasticity processes in adulthood. As an attempt to assess synaptic and developmental mechanisms by which PTEN can modulate cognitive function, we studied the consequences of 2 different genetic manipulations in mice: presence of additional genomic copies of the Pten gene (Ptentg) and knock-in of a truncated Pten gene lacking its PDZ motif (Pten-ΔPDZ), which is required for interaction with synaptic proteins. Ptentg mice exhibit substantial microcephaly, structural hypoconnectivity, enhanced synaptic depression at cortico-amygdala synapses, reduced anxiety, and intensified social interactions. In contrast, Pten-ΔPDZ mice have a much more restricted phenotype, with normal synaptic connectivity, but impaired synaptic depression at cortico-amygdala synapses and virtually abolished social interactions. These results suggest that synaptic actions of PTEN in the amygdala contribute to specific behavioral traits, such as sociability. Also, PTEN appears to function as a bidirectional rheostat in the amygdala: reduction in PTEN activity at synapses is associated with less sociability, whereas enhanced PTEN activity accompanies hypersocial behavior.


2009 ◽  
Vol 20 (4) ◽  
pp. 1120-1131 ◽  
Author(s):  
Huibin Tang ◽  
Peter Macpherson ◽  
Michael Marvin ◽  
Eric Meadows ◽  
William H. Klein ◽  
...  

Muscle activity contributes to formation of the neuromuscular junction and affects muscle metabolism and contractile properties through regulated gene expression. However, the mechanisms coordinating these diverse activity-regulated processes remain poorly characterized. Recently, it was reported that histone deacetylase 4 (HDAC4) can mediate denervation-induced myogenin and nicotinic acetylcholine receptor gene expression. Here, we report that HDAC4 is not only necessary for denervation-dependent induction of genes involved in synaptogenesis (nicotinic acetylcholine receptor and muscle-specific receptor tyrosine kinase) but also for denervation-dependent suppression of genes involved in glycolysis (muscle-specific enolase and phosphofructokinase). In addition, HDAC4 differentially regulates genes involved in muscle fiber type specification by inducing myosin heavy chain IIA and suppressing myosin heavy chain IIB. Consistent with these regulated gene profiles, HDAC4 is enriched in fast oxidative fibers of innervated tibialis anterior muscle and HDAC4 knockdown enhances glycolysis in cultured myotubes. HDAC4 mediates gene induction indirectly by suppressing the expression of Dach2 and MITR that function as myogenin gene corepressors. In contrast, HDAC4 is directly recruited to myocyte enhancer factor 2 sites within target promoters to mediate gene suppression. Finally, we discovered an HDAC4/myogenin positive feedback loop that coordinates gene induction and repression underlying muscle phenotypic changes after muscle denervation.


Sign in / Sign up

Export Citation Format

Share Document